Provider Portal

AllerGenis Allergy Diagnostic Company to Present Significant Milestones at the Biotech Showcase™ 2021 January 11, 2021
AllerGenis Presents at ACAAI 2020 Annual Meeting November 13-15, 2020
AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope Mapping Technology June 24, 2020
AllerGenis Announces Presentations at EAACI Digital Congress 2020 June 4, 2020
AllerGenis CEO Jim Garner joined by Proactive at the Biotech Showcase 2020 in San Francisco January 14, 2020
AllerGenis to Present at the 38th Annual J.P. Morgan Healthcare Conference January 8, 2020
New Research Demonstrates Clinical Viability of Epitope Mapping Technology Platform for Food Allergy Diagnosis December 23, 2019
AllerGenis to Showcase Latest Research Breakthroughs at EAACI Congress 2019 May 31, 2019
AllerGenis Granted Rights to Develop and Market Its Precision Food Allergy Diagnostic Using Luminex xMAP® Technology January 16, 2019
AllerGenis' Food Allergy Diagnostic Assay Demonstrates Significant Accuracy for Predicting Patient Outcomes in Milk Oral Immunotherapy December 3, 2018
Mount Sinai and AllerGenis, LLC partner to bring novel, precision diagnostics to food allergy patients. October 30, 2018
New food allergy diagnostics company, AllerGenis, recently launched to deliver innovative diagnostic technology enabling more precise food allergy detection and patient management. September 24, 2018
The Icahn School of Medicine at Mount Sinai Partners with Genisphere to Develop Rapid, High-Throughput Allergy Test January 31, 2013